• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Dermatology grant recipients examine veterinary otitis, atopic dermatitis

September 1, 2013

One veterinary team studying whether clients play role in canine otitis.

Two research teams have recently been awarded funding to study dermatologic problems in companion animals. One team, made up of researchers from the University of Pennsylvania School of Veterinary Medicine and Johns Hopkins University, will pursue research in Pseudomonas otitis in dogs. A second team at the University of Minnesota will examine the potential for a new drug target in atopic dermatitis. The grants were the first awarded by Zoetis as part of its Excellence in Dermatology Research Grant program.

About the proposals

Advertisement

The Penn-Johns Hopkins team is using its research funding to conduct an epidemiologic evaluation of Pseudomonas otitis in dogs—specifically, that pet owners may transmit the pathogen to their dogs. "Pseudomonas aeruginosa is commonly implicated in severe or chronic cases of otitis externa and otitis media in dogs, and the extensive antimicrobial resistance patterns of most isolates create major therapeutic challenges," says Daniel Morris, BS, DVM, MPH, DACVD, of Penn's veterinary school. "In our investigation of the epidemiology of Pseudomonas otitis, the data generated will be used to address two primary hypotheses: first, that the source of P. aeruginosa in canine otitis is the environment (most likely water and other fluids), and second, that the human companions of these dogs are the vehicles through which transmission and inoculation occur."

The University of Minnesota's research program is titled "A new drug target for improved epidermal barrier function in atopic dermatitis."

"Increased susceptibility to infections is a hallmark of atopic dermatitis, a chronic inflammatory skin disorder that affects approximately 10 to 20 percent of dogs," says Sheila Torres, BS, DVM, MS, PhD, DACVD. "This increased susceptibility is due in part to impaired epidermal barrier function, which leads to enhanced access of pathogenic bacteria to deeper epidermal layers."

The objective of the Minnesota project is to evaluate the relevance of the transient receptor potential channel (TRP) TRPV1 as a drug target for treatment of canine atopic dermatitis, Torres adds.

About the program

Excellence in Dermatology is a resource of clinical information and education materials for veterinarians, Zoetis says. It's designed to provide clinically relevant, evidence-based knowledge, along with insights from leading dermatology experts.

Related Content:

MedicalDermatology
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early
Performing surgery on dogs with GDV
Performing surgery on dogs with GDV
Not-so-ordinary ER cases you should know
Not-so-ordinary ER cases you should know

Advertisement

Latest News

San Francisco SPCA bestows $100k grant from San Francisco Foundation

Merck Animal Hospital renews scholarship with The Foundation for the Horse

3 Must-reads from Fetch Charlotte 2023

A practical approach to a fever of unknown origin

View More Latest News
Advertisement